Citadel Advisors’s EUDA Health Holdings Warrant EUDAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-13,653
Closed -$2.8K 14475
2024
Q2
$2.8K Buy
13,653
+3,069
+29% +$683 ﹤0.01% 13651
2024
Q1
$2.22K Buy
10,584
+373
+4% +$73 ﹤0.01% 14026
2023
Q4
$582 Buy
+10,211
New +$1.13K ﹤0.01% 13998

Other funds holding EUDAW

Citadel Advisors's EUDAW Position: Q3 2024 in Review

Citadel Advisors sold out of EUDA Health Holdings Warrant (EUDAW) in Q3 2024, closing a stake of 13,653 shares — an estimated $2.8K sold.

Citadel Advisors first reported a position in EUDAW in Q4 2023 and held it in 3 quarters. The position peaked at $2.8K in Q2 2024. 11 funds tracked by Wall St. Rank hold EUDAW as of Q3 2024.

  • Citadel Advisors reported no remaining EUDA Health Holdings Warrant position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 13,653 EUDA Health Holdings Warrant shares in Q3 2024, an estimated $2.8K.
  • Citadel Advisors first reported a position in EUDA Health Holdings Warrant in Q4 2023 and held it in 3 quarters.
  • Citadel Advisors's EUDA Health Holdings Warrant position peaked at $2.8K in Q2 2024.
  • 11 funds tracked by Wall St. Rank held EUDA Health Holdings Warrant as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.